HCID 11719201, compound → HCID 59428581, compound
Reaction equation
[CH:1]1([CH2:4][CH2:5][NH:6][C:7]([C:9]2[CH:10]=[CH:11][C:12]([C:15]3[CH2:16][CH2:17][N:18]([C:21](=[O:32])[C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=4[C:28]([F:31])([F:30])[F:29])[CH2:19][CH:20]=3)=[N:13][CH:14]=2)=[O:8])[CH2:3][CH2:2]1>CO.[Pd]>[CH:1]1([CH2:4][CH2:5][NH:6][C:7]([C:9]2[CH:10]=[CH:11][C:12]([CH:15]3[CH2:20][CH2:19][N:18]([C:21](=[O:32])[C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=4[C:28]([F:31])([F:29])[F:30])[CH2:17][CH2:16]3)=[N:13][CH:14]=2)=[O:8])[CH2:3][CH2:2]1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a stirred solution of 1′-(2-trifluoromethylbenzoyl)-1′,2′,3′,6′-tetrahydro-[2,4′]bipyridinyl-5-carboxylic acid (2-cyclopropylethyl)amide (0.030 g, 0.068 mmol) in methanol (5 mL) was added Pd/C (0.010 g, 12 mol %). The mixture was placed under an atmosphere of hydrogen for 24 hours and then filtered through celite. The filtrate was concentrated in vacuo. The crude product was purified by column chromatography to yield the title compound in 50% yield (0.015 g). 1H NMR (300 MHz, CDCl3) δ 8.91 (s, 1H), 8.12-8.08 (m, 1H), 7.71-7.67 (m, 1H), 7.60-7.47 (m, 2H), 7.38 (d, J=7.5 Hz, 1H), 7.31-7.22 (m, 1H), 6.62 (s, 1H), 4.95-4.85 (m, 1H), 3.55-3.41 (m, 3H), 3.18-2.84 (m, 3H), 2.07-2.02 (m, 1H), 1.92-1.65 (m, 2H), 1.52-1.45 (dd, J=6.9 and 7.0 Hz, 2H), 0.71-0.66 (m, 1H), 0.46-0.44 (m, 2H), 0.07-0.04 (m, 2H). 13C NMR (CDCl3, 75 MHz) δ 167.4, 166.0, 165.2, 147.1, 146.9, 136.6, 136.5, 132.3, 132.2, 129.1, 127.2, 121.1, 120.8, 47.4, 44.0, 41.8, 40.4, 34.3, 31.5, 30.7, 8.6, 4.2. MS (ES+) m/z 446.1 (M+1).
Workup
- filtrationfiltered through celite
- concentrationThe filtrate was concentrated in vacuo
- customThe crude product was purified by column chromatography
Sources & evidence
- ORD record
- ord-0b23c09a771d4aa7a3a95453f24a7c30
- Source dataset
- uspto-grants-2010_08
- Patent number
- US07777036B2
Reaction notes
Loading…